SCHEMBL15416669

SCHEMBL15416669

O=C(CN1CCCC1)n1cnc2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.52
RAD52 P43351 1/20 0.52
HTT P42858 1/20 0.51
ASAH1 Q13510 4/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 3/20 0.47
USP2 O75604 1/20 0.47
ALOX15 P16050 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 2/20 0.45
NPC1 O15118 2/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 1/20 0.45
HSD17B10 Q99714 1/20 0.45
LMNA P02545 1/20 0.44
STAT6 P42226 1/20 0.44
GAA P10253 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20604549 0.82 HTT (0.47) HTTASAH1KMT2AMEN1ALDH1A1
SCHEMBL7132708 0.78 ASAH1 (0.55) HTTASAH1KMT2AMEN1ALDH1A1
SCHEMBL11012986 0.76 NPC1 (0.57) HTTASAH1KMT2AMEN1ALDH1A1
SCHEMBL15416402 0.75 HTT (0.50) HTTASAH1KMT2AMEN1ALDH1A1
SCHEMBL32660141 0.75 ASAH1 (0.52) HTTASAH1KMT2AMEN1ALDH1A1
SCHEMBL7790594 0.74 ASAH1 (0.51) HTTASAH1KMT2AMEN1ALDH1A1
SCHEMBL1735988 0.74 ASAH1 (0.55) HTTASAH1KMT2AMEN1ALDH1A1
SCHEMBL15416672 0.73 LMNA (0.67) HTTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL11443588 0.73 KMT2A (0.60) HTTASAH1KMT2AMEN1ALDH1A1
SCHEMBL250172 0.73 HTT (0.66) HTTASAH1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872502-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2015-05-20 EP disclosed
WO-2014009302-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2014-01-16 WO disclosed